VentureBeat

Posts Tagged ‘inv:D.E.-Shaw’

Featured companies: BioVex, Cavadis, Innovention, Paratek Pharmaceuticals, Phase Bioscience, Reliant Pharmaceuticals, Xencor

UPDATED: Expanded Paratek and Xencor items.

paratek-logo.jpgParatek Pharma raises $40M for new antibiotics — Boston’s Paratek Pharmaceuticals, a biotech working on new antibiotics to treat drug-resistant bacterial infections, raised a first tranche of a $40 million eighth round of funding. The company’s release is here, VentureWire (subscription required) has more details here.

Investors in this funding included Aisling Capital, D.E. Shaw, Boston Life Science Venture Corporation, Nomura Phase4 Ventures, Novartis BioVentures, BioFund Ventures, HBM BioVentures, Lombard Odier Darier Hentsch, BioVeda Fund and Hercules Technology Growth Capital. Paratek’s lead drug candidate, PTK 0796, is being studied against skin-structure infections and community-acquired pneumonia.

xencor-logo.gifXencor raises additional $15M for cancer, immune-disease drugs — Xencor, a Monrovia, Calif., biotech developing “engineered” protein- and antibody-based drugs, raised an additional $15 million in its fifth funding round, bringing the total to $60 million. Investors included Oxford Bioscience Partners, Merlin Nexus, Novo Nordisk, MedImmune Ventures, HealthCare Ventures and Zen Investments.

Xenocor’s lead candidate is an antibody that could target Hodgkin’s disease and T-cell lymphoma. The company expects to begin early-stage human trials later this year.

HEADLINES OF NOTE:

Top Stories

Recent Comments

Powered by Disqus

Recent Guest Columnists

Job Board

Links

Venturebeat Writers

  • For advertising, contact .
  • Log in

Font Size

Silverpop, an Atlanta-based marketing technology firm that focuses on email, has taken $15 million in additional funds for expansion, despite reported profitability since 2004. Silverpop offers both business-to-customer and business-to-business marketing tools, and also provides measurement and analytics. The company is planning on expanding into the international market. The $15 million round was [...]

More ...